An extensive screening of GBA1 variants was previously performed by our team (Pachchek et al., 2023) using GBA1-targeted PacBio sequencing in individuals from the Luxembourg Parkinson’s study (660 PD patients, 100 patients with other forms of parkinsonism and 808 controls). This evidence concerns the gene GBA1 and Parkinson disease.